在小白色小鼠中,对环胺诱导的毒性进行保护时,Protocatechuic 酸的保护效果
Farrokhreza Kabir1, Niloufar Sadat Marashi2, Mahdi Goudarzi3
1Department of Clinical Sciences, Faculty of Veterinary Medicine, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Journal of biochemical and molecular toxicology
|October 23, 2025
概括
普罗托卡特丘酸可以保护脏免受常见的化疗药物环胺 (cyclophosphamide) 造成的损伤. 这项研究表明,它减少了小鼠脏中有害的生化标志物和氧化应激.
科学领域:
- 药理学和毒理学 药理学和毒理学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 自然产品化学 自然产品化学
背景情况:
- 环胺 (CP) 是一种用于治疗类风湿性关节炎和癌症的免疫抑制药物.
- 脑膜炎及其代谢物可以诱导急性膀炎症和损伤 (毒性).
- 益生菌酸 (PCA) 具有已知的抗炎,抗氧化和神经保护性质.
研究的目的:
- 在小鼠模型中研究原卡特丘酸对循环胺诱导的毒性产生保护作用.
- 评估PCA对CP治疗小鼠脏中的生化标志物和氧化应激的影响.
主要方法:
- 40只雄性小白小鼠被随机分配到五组:对照组,单纯的CP组和3组CP组,PCA剂量各不相同 (25,50,100毫克/公斤).
- 小鼠接受了10天的治疗;血液和脏组织被收集用于生物化学分析 (BUN,肌素,KIM-1,NGAL,氧化应激标志物).
- 进行脏组织病理学,使用血素和欧染色来评估组织损伤.
主要成果:
- 甲基酸显著降低了循环胺诱导的血清肌素,BUN,KIM-1和NGAL水平的升高.
- 经过PCA治疗,脏组织中的甲基,氧化和组织亡因子水平下降.
- 在脏组织中,PCA增加了抗氧化剂标记物,包括谷氨,总抗氧化能力,超氧化物脱氧化酶,催化酶和谷氨过氧化酶活性.
- 组织病理学检查证实PCA治疗组的损伤和管状亡减少,与仅使用CP的组相比.
结论:
- 在小鼠中,protocatechuic酸显示出显著的脏保护作用,防止循环胺诱导的脏损伤.
- 通过减少生化损伤标志物和减轻氧化应激,PCA可以减轻CP诱导的毒性.
- 这些发现表明,protocatechuic acid具有作为治疗剂的潜力,可以预防或治疗化疗引起的损伤.
相关概念视频
Acetals and Thioacetals as Protecting Groups for Aldehydes and Ketones
4.8K
Acetals are formed by reacting two equivalents of alcohol with carbonyl compounds like aldehydes or ketones. Acetals are unaffected by bases, nucleophiles, oxidizing agents, and reducing agents. They serve as protecting groups for aldehydes and ketones. Acetals can be easily formed and also easily removed via mild acid hydrolysis.
In the presence of multiple functional groups, when selective reduction of one group over the other is desired, groups like aldehydes and ketones that form acetals...
In the presence of multiple functional groups, when selective reduction of one group over the other is desired, groups like aldehydes and ketones that form acetals...
4.8K
Protecting Groups for Aldehydes and Ketones: Introduction
7.0K
Protecting groups are compounds that can bind to a specific functional group in the presence of other functional groups to protect them from undesired chemical reactions. These compounds can selectively bind to particular functional groups and advance chemoselective reactions in polyfunctional systems (Figure 1). After the functional group has served its purpose, it is removed by reacting it with specific compounds.
7.0K
Prevention of Further Absorption of Poison
1.4K
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.4K
Indirect-Acting Cholinergic Agonists: Mechanism of Action
2.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.8K
Anticholinesterase Agents: Poisoning and Treatment
2.0K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
2.0K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
3.2K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
3.2K


